Firm News

Home 9 News Item 9 Wiggin and Dana Represents IsoPlexis in Series C-2 Funding Round

Wiggin and Dana Represents IsoPlexis in Series C-2 Funding Round

January 14, 2020

Wiggin and Dana represented its client, IsoPlexis, the leader in single-cell functional proteomics, in raising $20M in its Series C-2 financing led by Northpond Ventures LP.

For more information about IsoPlexisโ€™ expansion plans, please click here.

Resources

Firm Highlights